Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform

Experimental and Molecular Medicine

Volumn 45, Issue 3, 2013, Pages

  Han, Hui ^a   Wang, Yu Hong ^a   Qu, Guang Jin ^a   Sun, Ting Ting ^a   Li, Feng Qing ^a   Jiang, Wei ^a   Luo, Shan Shun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E knockout mice; Atherosclerosis; Genome microarray; miRNA microarray; SOCS pathway

Indexed keywords

APOLIPOPROTEIN E; MICRORNA; MICRORNA 19B; MICRORNA 30A; MICRORNA 30E; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; MESSENGER RNA; SOCS3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC ANALYSIS; HIGH THROUGHPUT SCREENING; MALE; MICROARRAY ANALYSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; AORTA; BIOLOGICAL MODEL; C57BL MOUSE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REPRODUCIBILITY; UPREGULATION;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84875856494     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.31     Document Type: Article

References (42)

1. Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 2005; 77: 1-15.
2. Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. J Lipid Res 2009; 50 (Suppl): S178-S182.
3. Bonenfant M, Provost PR, Drolet R, Tremblay Y. Localization of type 1 17beta-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi. J Endocrinol 2000; 165: 217-222. (Pubitemid 30341070)
4. Moretti F, Thermann R, Hentze MW. Mechanism of translational regulation by miR-2 from sites in the 50 untranslated region or the open reading frame. RNA 2010; 16: 2493-2502.
5. Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 2009; 83: 131-139.
6. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588. (Pubitemid 46897261)
7. Zhang Q, Kandic I, Kutryk MJ. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun 2011; 405: 42-46.
8. Huang X, Le QT, Giaccia AJ. MiR-210 - micromanager of the hypoxia pathway. Trends Mol Med 2010; 16: 230-237.
9. Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov 2009; 4: 109-118.
10. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31: 367-373. (Pubitemid 350127777)
11. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 2010; 107: 13450-13455.
12. Izumiya M, Tsuchiya N, Okamoto K, Nakagama H. Systematic exploration of cancer-associated microRNA through functional screening assays. Cancer Sci 2011; 102: 1615-1621.
13. Liu J, Zheng M, Tang YL, Liang XH, Yang Q. MicroRNAs an active and versatile group in cancers. Int J Oral Sci 2011; 3: 165-175.
14. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011; 91: 827-887.
15. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007; 5: e203.
16. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 2007; 104: 17016-17021. (Pubitemid 350210983)
17. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 2007; 170: 1831-1840. (Pubitemid 47339258)
18. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012; 30: 295-312.
19. Zernecke A. MicroRNAs in the regulation of immune cell functions - implications for atherosclerotic vascular disease. Thromb Haemost 2012; 107: 626-633.
20. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009; 81: 717-729.
21. Jawien J, Nastalek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol 2004; 55: 503-517. (Pubitemid 39318844)
22. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993; 91: 2572-2579. (Pubitemid 23182511)
23. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992; 89: 4471-4475.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924. (Pubitemid 19101597)
25. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-471.
26. Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis 2011; 2: e137.
27. Carruth LM, Demczuk S, Mizel SB. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J Biol Chem 1991; 266: 12162-12167. (Pubitemid 21907072)
28. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011; 219: 211-217.
29. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009; 1792: 497-505.
30. Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 2010; 58: 961-967.
31. Kishida K, Funahashi T, Shimomura I. Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin. Endocr Metab Immune Disord Drug Targets 2012; 12: 118-131.
32. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC et al. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat 2012; 134: 1081-1093.
33. Watson KE, Peters Harmel AL, Matson G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. J Cardiovasc Pharmacol Ther 2003; 8: 253-260. (Pubitemid 38045076)
34. Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocytespecific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 2011; 12: R64.
35. Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes 2010; 17: 150-155.
36. Yin R, Bao W, Xing Y, Xi T, Gou S. MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells. Biochem Biophys Res Commun 2012; 417: 771-776.
37. Ortiz-Munoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O et al. Suppressors of cytokine signalling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 525-531.
38. Xu X, Wang Q, Deng B, Wang H, Dong Z, Qu X et al. Monocyte Chemoattractant Protein-1 Secreted by Decidual Stromal Cells Inhibits NK Cells Cytotoxicity by Up-Regulating Expression of SOCS3. PloS One 2012; 7: e41869.
39. Tang J, Kozaki K, Farr AG, Martin PJ, Lindahl P, Betsholtz C et al. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice. Am J Pathol 2005; 167: 901-912. (Pubitemid 41216372)
40. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL et al. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb 1994; 14: 1480-1497.
41. Roselaar SE, Kakkanathu PX, Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. Atertio Thromb Vasc Biol 1996; 16: 1013-1018. (Pubitemid 26266901)
42. Qiao JH, Castellani LW, Fishbein MC, Lusis AJ. Immune-complexmediated vasculitis increases coronary artery lipid accumulation in autoimmune- prone MRL mice. Arterioscler Thromb 1993; 13: 932-943. (Pubitemid 23164698)